HEADER TRANSFERASE 02-AUG-10 2XNG TITLE STRUCTURE OF AURORA-A BOUND TO A SELECTIVE IMIDAZOPYRAZINE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE 6; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 122-392; COMPND 5 SYNONYM: AURORA KINASE A, SERINE/THREONINE-PROTEIN KINASE AURORA-A, COMPND 6 SERINE/THREONINE-PROTEIN KINASE 15, AURORA/IPL1-RELATED KINASE 1, COMPND 7 BREAST TUMOR-AMPLIFIED KINASE, AURORA-RELATED KINASE 1, ARK-1, HARK1; COMPND 8 EC: 2.7.11.1; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SER-THR PROTEIN KINASE COMPLEX, PROTO-ONCOGENE, KINASE, MITOSIS, CELL KEYWDS 2 CYCLE, MICROTUBULE, TRANSFERASE, CYTOSKELETON, CELL DIVISION EXPDTA X-RAY DIFFRACTION AUTHOR M.KOSMOPOULOU,R.BAYLISS REVDAT 4 20-DEC-23 2XNG 1 REMARK REVDAT 3 28-FEB-18 2XNG 1 JRNL REVDAT 2 29-SEP-10 2XNG 1 JRNL REVDAT 1 22-SEP-10 2XNG 0 JRNL AUTH N.BOULOC,J.M.LARGE,M.KOSMOPOULOU,C.SUN,A.FAISAL,M.MATTEUCCI, JRNL AUTH 2 J.REYNISSON,N.BROWN,B.ATRASH,J.BLAGG,E.MCDONALD, JRNL AUTH 3 S.LINARDOPOULOS,R.BAYLISS,V.BAVETSIAS JRNL TITL STRUCTURE-BASED DESIGN OF IMIDAZO[1,2-A]PYRAZINE DERIVATIVES JRNL TITL 2 AS SELECTIVE INHIBITORS OF AURORA-A KINASE IN CELLS. JRNL REF BIOORG. MED. CHEM. LETT. V. 20 5988 2010 JRNL REFN ESSN 1464-3405 JRNL PMID 20833547 JRNL DOI 10.1016/J.BMCL.2010.08.091 REMARK 2 REMARK 2 RESOLUTION. 2.61 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.61 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 71.10 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.410 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 11101 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.224 REMARK 3 R VALUE (WORKING SET) : 0.221 REMARK 3 FREE R VALUE : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 531 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 71.1237 - 4.1353 1.00 2814 125 0.2174 0.2490 REMARK 3 2 4.1353 - 3.2823 1.00 2622 128 0.1937 0.2442 REMARK 3 3 3.2823 - 2.8674 1.00 2563 156 0.2197 0.3122 REMARK 3 4 2.8674 - 2.6052 1.00 2571 122 0.2505 0.3251 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.35 REMARK 3 B_SOL : 49.17 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.380 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.400 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.01630 REMARK 3 B22 (A**2) : -3.01630 REMARK 3 B33 (A**2) : 6.03260 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2067 REMARK 3 ANGLE : 1.281 2823 REMARK 3 CHIRALITY : 0.069 308 REMARK 3 PLANARITY : 0.005 354 REMARK 3 DIHEDRAL : 20.289 721 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2XNG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-AUG-10. REMARK 100 THE DEPOSITION ID IS D_1290044932. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-SEP-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9334 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11148 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 86.070 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 6.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 11.00 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 25.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 99.90 REMARK 200 R MERGE FOR SHELL (I) : 0.34000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 1OL7 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.27 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.75 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.20933 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 114.41867 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 85.81400 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 143.02333 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 28.60467 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 57.20933 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 114.41867 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 143.02333 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 85.81400 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 28.60467 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 121 REMARK 465 GLU A 122 REMARK 465 SER A 123 REMARK 465 LYS A 124 REMARK 465 LYS A 125 REMARK 465 ARG A 126 REMARK 465 PRO A 282 REMARK 465 SER A 283 REMARK 465 SER A 284 REMARK 465 ARG A 285 REMARK 465 ARG A 286 REMARK 465 THR A 287 REMARK 465 THR A 288 REMARK 465 LEU A 289 REMARK 465 CYS A 290 REMARK 465 GLY A 291 REMARK 465 SER A 391 REMARK 465 ASN A 392 REMARK 465 CYS A 393 REMARK 465 GLN A 394 REMARK 465 ASN A 395 REMARK 465 LYS A 396 REMARK 465 GLU A 397 REMARK 465 SER A 398 REMARK 465 ALA A 399 REMARK 465 SER A 400 REMARK 465 LYS A 401 REMARK 465 GLN A 402 REMARK 465 SER A 403 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 127 CG CD OE1 NE2 REMARK 470 GLU A 131 CG CD OE1 OE2 REMARK 470 LYS A 141 CG CD CE NZ REMARK 470 LYS A 143 CG CD CE NZ REMARK 470 ASN A 146 CG OD1 ND2 REMARK 470 LYS A 166 CG CD CE NZ REMARK 470 GLN A 168 CG CD OE1 NE2 REMARK 470 LEU A 169 CG CD1 CD2 REMARK 470 GLU A 170 CG CD OE1 OE2 REMARK 470 LYS A 171 CG CD CE NZ REMARK 470 VAL A 174 CG1 CG2 REMARK 470 GLU A 175 CG CD OE1 OE2 REMARK 470 HIS A 176 CG ND1 CD2 CE1 NE2 REMARK 470 GLN A 177 CG CD OE1 NE2 REMARK 470 ARG A 179 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 180 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 183 CG CD OE1 OE2 REMARK 470 ARG A 189 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 205 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 220 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 224 CG CD CE NZ REMARK 470 GLN A 231 CG CD OE1 NE2 REMARK 470 LYS A 250 CG CD CE NZ REMARK 470 ARG A 251 CG CD NE CZ NH1 NH2 REMARK 470 TRP A 277 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 277 CZ3 CH2 REMARK 470 HIS A 280 CG ND1 CD2 CE1 NE2 REMARK 470 MET A 305 CG SD CE REMARK 470 GLU A 336 CG CD OE1 OE2 REMARK 470 LYS A 339 CG CD CE NZ REMARK 470 GLU A 354 CG CD OE1 OE2 REMARK 470 ARG A 375 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 389 CG CD CE NZ REMARK 470 PRO A 390 CA C O CB CG CD REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 131 6.87 -69.18 REMARK 500 LYS A 143 -74.91 -69.26 REMARK 500 PHE A 200 -179.37 -176.70 REMARK 500 ASP A 202 -133.95 -124.33 REMARK 500 SER A 226 -63.99 75.94 REMARK 500 ARG A 255 -21.18 78.84 REMARK 500 ASP A 274 70.43 56.36 REMARK 500 PHE A 275 38.13 -73.62 REMARK 500 ARG A 304 170.37 -38.91 REMARK 500 ASP A 307 -160.97 -123.88 REMARK 500 GLU A 308 -8.39 -54.82 REMARK 500 LEU A 364 56.81 -91.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE A0H A 1391 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1MUO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AURORA-2, AN ONCOGENIC SERINE-THREONINE KINASE REMARK 900 RELATED ID: 2X6D RELATED DB: PDB REMARK 900 AURORA-A BOUND TO AN INHIBITOR REMARK 900 RELATED ID: 2J50 RELATED DB: PDB REMARK 900 STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA -739358 REMARK 900 RELATED ID: 2W1D RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 1OL6 RELATED DB: PDB REMARK 900 STRUCTURE OF UNPHOSPHORYLATED D274N MUTANT OF AURORA-A REMARK 900 RELATED ID: 2BMC RELATED DB: PDB REMARK 900 AURORA-2 T287D T288D COMPLEXED WITH PHA- 680632 REMARK 900 RELATED ID: 2J4Z RELATED DB: PDB REMARK 900 STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA -680626 REMARK 900 RELATED ID: 2C6E RELATED DB: PDB REMARK 900 AURORA A KINASE ACTIVATED MUTANT (T287D) IN COMPLEX WITH A 5- REMARK 900 AMINOPYRIMIDINYL QUINAZOLINE INHIBITOR REMARK 900 RELATED ID: 1OL5 RELATED DB: PDB REMARK 900 STRUCTURE OF AURORA-A 122-403, PHOSPHORYLATED ON THR287, THR288 AND REMARK 900 BOUND TO TPX2 1-43 REMARK 900 RELATED ID: 2X81 RELATED DB: PDB REMARK 900 STRUCTURE OF AURORA A IN COMPLEX WITH MLN8054 REMARK 900 RELATED ID: 2C6D RELATED DB: PDB REMARK 900 AURORA A KINASE ACTIVATED MUTANT (T287D) IN COMPLEX WITH ADPNP REMARK 900 RELATED ID: 2WTW RELATED DB: PDB REMARK 900 AURORA-A INHIBITOR STRUCTURE (2ND CRYSTAL FORM) REMARK 900 RELATED ID: 2WQE RELATED DB: PDB REMARK 900 STRUCTURE OF S155R AURORA-A SOMATIC MUTANT REMARK 900 RELATED ID: 2W1C RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 2W1G RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 2WTV RELATED DB: PDB REMARK 900 AURORA-A INHIBITOR STRUCTURE REMARK 900 RELATED ID: 1OL7 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN AURORA-A 122-403 PHOSPHORYLATED ON THR287, THR288 REMARK 900 RELATED ID: 2W1E RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 2W1F RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 2X6E RELATED DB: PDB REMARK 900 AURORA-A BOUND TO AN INHIBITOR REMARK 900 RELATED ID: 1MQ4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AURORA-A PROTEIN KINASE REMARK 900 RELATED ID: 2XNE RELATED DB: PDB REMARK 900 STRUCTURE OF AURORA-A BOUND TO AN IMIDAZOPYRAZINE INHIBITOR DBREF 2XNG A 122 403 UNP O14965 STK6_HUMAN 122 403 SEQADV 2XNG MET A 121 UNP O14965 EXPRESSION TAG SEQRES 1 A 283 MET GLU SER LYS LYS ARG GLN TRP ALA LEU GLU ASP PHE SEQRES 2 A 283 GLU ILE GLY ARG PRO LEU GLY LYS GLY LYS PHE GLY ASN SEQRES 3 A 283 VAL TYR LEU ALA ARG GLU LYS GLN SER LYS PHE ILE LEU SEQRES 4 A 283 ALA LEU LYS VAL LEU PHE LYS ALA GLN LEU GLU LYS ALA SEQRES 5 A 283 GLY VAL GLU HIS GLN LEU ARG ARG GLU VAL GLU ILE GLN SEQRES 6 A 283 SER HIS LEU ARG HIS PRO ASN ILE LEU ARG LEU TYR GLY SEQRES 7 A 283 TYR PHE HIS ASP ALA THR ARG VAL TYR LEU ILE LEU GLU SEQRES 8 A 283 TYR ALA PRO LEU GLY THR VAL TYR ARG GLU LEU GLN LYS SEQRES 9 A 283 LEU SER LYS PHE ASP GLU GLN ARG THR ALA THR TYR ILE SEQRES 10 A 283 THR GLU LEU ALA ASN ALA LEU SER TYR CYS HIS SER LYS SEQRES 11 A 283 ARG VAL ILE HIS ARG ASP ILE LYS PRO GLU ASN LEU LEU SEQRES 12 A 283 LEU GLY SER ALA GLY GLU LEU LYS ILE ALA ASP PHE GLY SEQRES 13 A 283 TRP SER VAL HIS ALA PRO SER SER ARG ARG THR THR LEU SEQRES 14 A 283 CYS GLY THR LEU ASP TYR LEU PRO PRO GLU MET ILE GLU SEQRES 15 A 283 GLY ARG MET HIS ASP GLU LYS VAL ASP LEU TRP SER LEU SEQRES 16 A 283 GLY VAL LEU CYS TYR GLU PHE LEU VAL GLY LYS PRO PRO SEQRES 17 A 283 PHE GLU ALA ASN THR TYR GLN GLU THR TYR LYS ARG ILE SEQRES 18 A 283 SER ARG VAL GLU PHE THR PHE PRO ASP PHE VAL THR GLU SEQRES 19 A 283 GLY ALA ARG ASP LEU ILE SER ARG LEU LEU LYS HIS ASN SEQRES 20 A 283 PRO SER GLN ARG PRO MET LEU ARG GLU VAL LEU GLU HIS SEQRES 21 A 283 PRO TRP ILE THR ALA ASN SER SER LYS PRO SER ASN CYS SEQRES 22 A 283 GLN ASN LYS GLU SER ALA SER LYS GLN SER HET A0H A1391 70 HETNAM A0H N-(3-{3-CHLORO-8-[(4-MORPHOLIN-4-YLPHENYL) HETNAM 2 A0H AMINO]IMIDAZO[1,2-A]PYRAZIN-6-YL}BENZYL) HETNAM 3 A0H METHANESULFONAMIDE FORMUL 2 A0H C24 H25 CL N6 O3 S FORMUL 3 HOH *25(H2 O) HELIX 1 1 ALA A 129 GLU A 131 5 3 HELIX 2 2 LYS A 166 ALA A 172 1 7 HELIX 3 3 VAL A 174 LEU A 188 1 15 HELIX 4 4 THR A 217 SER A 226 1 10 HELIX 5 5 ASP A 229 LYS A 250 1 22 HELIX 6 6 LYS A 258 GLU A 260 5 3 HELIX 7 7 PRO A 297 GLU A 302 1 6 HELIX 8 8 LYS A 309 GLY A 325 1 17 HELIX 9 9 THR A 333 ARG A 343 1 11 HELIX 10 10 THR A 353 LEU A 364 1 12 HELIX 11 11 ASN A 367 ARG A 371 5 5 HELIX 12 12 MET A 373 GLU A 379 1 7 HELIX 13 13 HIS A 380 SER A 387 1 8 SHEET 1 AA 5 PHE A 133 LYS A 141 0 SHEET 2 AA 5 ASN A 146 GLU A 152 -1 O VAL A 147 N LEU A 139 SHEET 3 AA 5 ILE A 158 PHE A 165 -1 O LEU A 159 N ALA A 150 SHEET 4 AA 5 ARG A 205 LEU A 210 -1 O VAL A 206 N LEU A 164 SHEET 5 AA 5 LEU A 196 HIS A 201 -1 N TYR A 197 O ILE A 209 SHEET 1 AB 2 LEU A 262 LEU A 264 0 SHEET 2 AB 2 LEU A 270 ILE A 272 -1 O LYS A 271 N LEU A 263 SITE 1 AC1 18 ARG A 137 LEU A 139 GLY A 140 LYS A 141 SITE 2 AC1 18 ALA A 160 LEU A 210 GLU A 211 TYR A 212 SITE 3 AC1 18 ALA A 213 PRO A 214 GLY A 216 THR A 217 SITE 4 AC1 18 TYR A 219 ARG A 220 LEU A 263 SER A 342 SITE 5 AC1 18 ARG A 343 HIS A 366 CRYST1 82.096 82.096 171.628 90.00 90.00 120.00 P 61 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012181 0.007033 0.000000 0.00000 SCALE2 0.000000 0.014065 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005827 0.00000